Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Connexin 37, Connexin 43 on Clinical Disease Phenotype in Delta F508 Homozygous Patients With Cystic Fibrosis (CF) (CF-Modifier)

NCT04242420 is registered in ClinicalTrials.gov with University Childrens' Hospital (Zentrum für Kinderheilkunde des Universitätsklinikum Bonn) as lead sponsor.

NCT NCT04242420
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04242420 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Connexin 37, Connexin 43 on Clinical Disease Phenotype in Delta F508 Homozygous Patients With Cystic Fibrosis (CF) (CF-Modifier)
Lead sponsor
University Childrens' Hospital (Zentrum für Kinderheilkunde des Universitätsklinikum Bonn)
Phase
Not applicable
Overall status
Unknown status
Start date
April 30, 2002
Completion date
December 31, 2024
Enrollment
300 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

cystic fibrosis, inflammation